CECR9

Across TCGA pan-cancer cohorts, CECR9 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CECR9 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CECR9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CECR9 expression acts as an unfavorable survival marker, although some lineages such as LIHC and BLCA show a favorable association.

LUAD, LIHC, and COAD are the cancer types where CECR9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.513	0.802	<.001	72	view →
LIHC	DFS	Quartile	III,IV	0.560	0.124	.002	38	view →
COAD	OS	Tertile	All	0.799	0.887	.004	28	view →
BLCA	DFS	Tertile	All	0.780	0.547	.018	24	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
KIRC	OS	Tertile	All	0.713	0.890	.017	18	view →
THYM	DFS	Tertile	All	0.145	0.736	<.001	18	view →
LUSC	DFS	Tertile	All	0.676	0.442	.040	6	view →
KIRP	OS	Tertile	All	0.781	0.935	.038	3	view →
HNSC	DFS	Quartile	III,IV	0.759	0.653	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

CECR9–LUAD (OS)

Open the LUAD breakdown →